glp-1 eli lilly is now pharma's top revenue company. It just got FDA approval for an oral GLP-1, but Wall Street isn't celebrating Novo, Lilly weight-loss drugs should

Table 5 showed that in the CT group, mental fatigue did not change significantly, while physical and fatigue severity score significantly increased after modified fasting therapy

It is vital for patients to have open discussions with their healthcare providers about these concerns, as well as to explore the potential benefits that may outweigh the risks

What the trial data shows

Patients who are pregnant or planning to become pregnant should discuss the risks with their clinician before starting treatment

Copper is required for oncogenic BRAF signalling and tumorigenesis

Human relevance would require sufficient published, peer-reviewed controlled human studies, appropriate regulatory review, pharmacokinetic characterization, toxicology data, and long-term safety evaluation